Serum HBV RNA as a Predictive Biomarker for HBeAg Seroconversion During Entecavir and Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients
HBV RNA is a promising biomarker to predict HBeAg seroconversion during NAs therapy. Its use could enhance personalized treatment strategies for CHB patients.
Authors
- Huiling Kang (ORCID: https://orcid.org/0000-0002-7610-0281)
- Ronghua Chen (ORCID: https://orcid.org/0000-0001-6863-530X)
- Lijuan Liu (ORCID: https://orcid.org/0000-0002-8538-5661)
- Wennan Wu
- Er Huang
- Shu Wu
Institutions
- Fujian Medical University (CN)
- Mengchao Hepatobiliary Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Revista Española de Enfermedades Digestivas
- Published
- 2025-01-01
- DOI
- https://doi.org/10.17235/reed.2025.11226/2025
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35